RBx-8444

N/A

Report date: 2024/12/05 11:22:59
NME

Base Information

Drug NameRBx-8444
Drug Alias NameAE-9C90CBRBx-7643RBx-8444RBx-9611
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMuscarinic acetylcholine receptor M3 antagonists
TargetsMuscarinic acetylcholine receptor M3
Therapy Area/IndicationsUrinary Bladder, Overactive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRanbaxy Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRanbaxy Laboratories
Active IndicationsN/A
Inactive IndicationsUrinary Bladder, Overactive

Other Information

ATC CodeN/A
Related LinksN/A